Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.

Bellcross CA, Leadbetter S, Alford SH, Peipins LA.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):728-35. doi: 10.1158/1055-9965.EPI-12-1280. Epub 2013 Jan 31.

2.

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.

Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R.

Ann Intern Med. 2014 Feb 18;160(4):255-66. Review.

PMID:
24366442
3.

BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

Sinilnikova OM, Mazoyer S, Bonnardel C, Lynch HT, Narod SA, Lenoir GM.

Fam Cancer. 2006;5(1):15-20. Review.

PMID:
16528604
4.

BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.

Nicoletto MO, Donach M, De Nicolo A, Artioli G, Banna G, Monfardini S.

Cancer Treat Rev. 2001 Oct;27(5):295-304. Review.

PMID:
11871866
5.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force.

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
16144895
6.

Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.

D'Andrea E, Marzuillo C, De Vito C, Di Marco M, Pitini E, Vacchio MR, Villari P.

Genet Med. 2016 Dec;18(12):1171-1180. doi: 10.1038/gim.2016.29. Epub 2016 Apr 14. Review.

7.

Counseling the at risk patient in the BRCA1 and BRCA2 Era.

Barnes-Kedar IM, Plon SE.

Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. Review.

PMID:
12108833
8.

Finding all BRCA pathogenic mutation carriers: best practice models.

Hoogerbrugge N, Jongmans MC.

Eur J Hum Genet. 2016 Sep;24 Suppl 1:S19-26. doi: 10.1038/ejhg.2016.95. Review.

9.

Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility [Internet].

Nelson HD, Huffman LH, Fu R, Harris EL, Walker M, Bougatsos C.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Sep.

10.

Genetic Counseling Overview for the Obstetrician-Gynecologist.

Hoskovec JM, Stevens BK.

Obstet Gynecol Clin North Am. 2018 Mar;45(1):1-12. doi: 10.1016/j.ogc.2017.10.008. Review.

PMID:
29428277

Supplemental Content

Support Center